Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
NCT ID: NCT03650114
Last Updated: 2025-11-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
PHASE3
1882 participants
INTERVENTIONAL
2018-12-28
2028-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Vaccination sub-study The purpose of this research sub-study is to find out the effects of ofatumumab on the development of antibody responses to selected vaccines and keyhole limpet hemocyanin (KLH) neo-antigen in subjects with relapsing multiple sclerosis (RMS).
COVID-19 sub-study:
The purpose of this research sub-study is to explore the immune response following Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination in a subset of subjects on long-term ofatumumab 20 mg sc. Note: Novartis is not supplying the SARS-CoV-2 vaccine.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ofatumumab
Subcutaneous injection
Ofatumumab
subcutaneous injection of 20 mg ofatumumab every 4 weeks
Tetanus toxoid (TT) containing vaccine (Td, Tdap)
0.5mL Vial/Syringe Containing 5 limit of flocculation (LF) tetanus toxoid
13-valent pneumococcal conjugate vaccine (13-PCV)
0.5mL Vial/Syringe
23-valent pneumococcal polysaccharide vaccine (23-PPV)
0.5mL Vial/Syringe
Seasonal Quadrivalent influenza vaccine
Seasonal 2020-2021 0.5mL Vial/Syringe (trivalent may be used where quadrivalent is not available)
Keyhole limpet hemocyanin (KLH) neo-antigen
1mg Vial
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ofatumumab
subcutaneous injection of 20 mg ofatumumab every 4 weeks
Tetanus toxoid (TT) containing vaccine (Td, Tdap)
0.5mL Vial/Syringe Containing 5 limit of flocculation (LF) tetanus toxoid
13-valent pneumococcal conjugate vaccine (13-PCV)
0.5mL Vial/Syringe
23-valent pneumococcal polysaccharide vaccine (23-PPV)
0.5mL Vial/Syringe
Seasonal Quadrivalent influenza vaccine
Seasonal 2020-2021 0.5mL Vial/Syringe (trivalent may be used where quadrivalent is not available)
Keyhole limpet hemocyanin (KLH) neo-antigen
1mg Vial
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Written informed consent
1. Informed consent
2. Actively enrolled in the COMB157G2399 Study
3. 12 weeks of continuous treatment within the COMB157G2399 Study
4. prior vaccination history as per protocol-defined
Exclusion Criteria
* Subjects with active systemic bacterial, viral or fingal infections, or chronic infection (e.g. AIDS)
* Subjects taking medications prohibited by the protocol
Vaccination sub-study:
* known hypersensitivity or history of systemic allergic, neurologic or other reactions to vaccines
* allergies to egg or shellfish
* any safety findings including low IgG/IgM requiring ofatumumab interruption within 12 weeks prior to vaccination sub-study start
* any major episode of infection requiring hospitalization or treatment with intravenous antibiotics within 2 weeks of the first vaccination sub-study visit
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novartis Pharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama at Birmingham
Birmingham, Alabama, United States
North Central Neurology Associates PC
Cullman, Alabama, United States
Barrow Neurological Clinics at St Josephs Hospital and MC
Phoenix, Arizona, United States
Fullerton Neuro and Headache Ctr
Fullerton, California, United States
University of California Davis
Sacramento, California, United States
CU Anschutz Med Campus
Aurora, Colorado, United States
Mountain Neuro Research Center PC
Basalt, Colorado, United States
Alpine Clinical Research Center
Boulder, Colorado, United States
Colorado Springs Neurological Associates
Colorado Springs, Colorado, United States
Colorado Neurological Research PC
Denver, Colorado, United States
University of Colorado Health Neurology
Fort Collins, Colorado, United States
Christiana Care Health Services
Newark, Delaware, United States
Jem Research Institute
Atlantis, Florida, United States
Neurology Offices of South Florida PLLC
Delray Beach, Florida, United States
Infinity Clinical Research LLC
Hollywood, Florida, United States
Homestead Assoc In Research Inc
Homestead, Florida, United States
Neurology Associates PA
Maitland, Florida, United States
UM Department Of Neurology
Miami, Florida, United States
Aqualane Clinical Research
Naples, Florida, United States
MS and Neuromuscular Center of Excellence
Oldsmar, Florida, United States
Neurology Associates of Ormond Beach
Ormond Beach, Florida, United States
Emerald Coast Neurology
Pensacola, Florida, United States
Neurostudies Inc
Port Charlotte, Florida, United States
Negroski Neurology
Sarasota, Florida, United States
Roskamp Institute Inc
Sarasota, Florida, United States
AMO Corporation
Tallahassee, Florida, United States
Clinical Research of West Florida Inc
Tampa, Florida, United States
Axiom Clinical Research of Florida
Tampa, Florida, United States
University Of South Florida
Tampa, Florida, United States
Premiere Research Institute
West Palm Beach, Florida, United States
Velocity Clinical Research
Savannah, Georgia, United States
Georgia Neurology and Sleep Medicine Assoc
Suwanee, Georgia, United States
Hawaii Pacific Neuroscience LLC
Honolulu, Hawaii, United States
Rush University Medical Center
Chicago, Illinois, United States
Consultants in Neurology
Northbrook, Illinois, United States
Josephson Wallack Munshower Neurology P.C
Indianapolis, Indiana, United States
University of Kansas Hospital
Kansas City, Kansas, United States
College Park Family Care Center
Overland Park, Kansas, United States
Neuro Medical Clinic of Cenla LLC
Alexandria, Louisiana, United States
The Neuromedical Center
Baton Rouge, Louisiana, United States
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Dragonfly Research LLC
Wellesley Hills, Massachusetts, United States
Wayne State University Multiple Sclerosis Clinic
Detroit, Michigan, United States
Henry Ford Hospital
Detroit, Michigan, United States
Sharlin Health and Neurology
Ozark, Missouri, United States
WA Uni School Of Med
St Louis, Missouri, United States
Mercy Research
St Louis, Missouri, United States
Billings Clinic
Billings, Montana, United States
Advanced Neurology Specialists
Great Falls, Montana, United States
Cleveland Clinic Foundation
Las Vegas, Nevada, United States
University of New Mexico
Albuquerque, New Mexico, United States
Ms Ctr Of Northeastern Ny
Latham, New York, United States
Asheville Neurology Specialists PA
Asheville, North Carolina, United States
The Neurological Institute PA
Charlotte, North Carolina, United States
Guilford Neurologic Associate Research
Greensboro, North Carolina, United States
Velocity Clinical Research
Raleigh, North Carolina, United States
PMG Research of Winston Salem
Winston-Salem, North Carolina, United States
Neurology and Neuroscience Assos
Akron, Ohio, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Ohio Health Research Institute
Columbus, Ohio, United States
Columbus Neuroscience
Westerville, Ohio, United States
Multiple Sclerosis Center of Excellence of OMRF
Oklahoma City, Oklahoma, United States
Providence Neurological Services West
Portland, Oregon, United States
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
Abington Neurological Associates Ltd
Willow Grove, Pennsylvania, United States
Premier Neurology
Greenville, South Carolina, United States
BG Neurology
Spartanburg, South Carolina, United States
Upstate Clinical Trials LLC
Spartanburg, South Carolina, United States
Wesley Neurology Clinic
Cordova, Tennessee, United States
Tri State Mountain Neurology
Johnson, Tennessee, United States
University of Tennessee Medical Ctr
Knoxville, Tennessee, United States
Sibyl Wray MD Neurology PC
Knoxville, Tennessee, United States
Med Research Inc
El Paso, Texas, United States
Neurology and Sleep Center
Lubbock, Texas, United States
Central TX Neuro Consultants P A
Round Rock, Texas, United States
Lonestar Neurology of San Antonio
San Antonio, Texas, United States
Texas Institute for Neurological Disorders
Sherman, Texas, United States
Rocky Mountain MS Clinic
Salt Lake City, Utah, United States
The University of Utah
Salt Lake City, Utah, United States
Sentara Neuroscience Institute
Virginia Beach, Virginia, United States
Evergreen Health Multiple Sclerosis Center
Kirkland, Washington, United States
MultiCare Research Institute for Research and Innovation
Tacoma, Washington, United States
Aurora BayCare Medical Center
Green Bay, Wisconsin, United States
University of Wisconsin Madison
Madison, Wisconsin, United States
Ascension St Francis Center
Milwaukee, Wisconsin, United States
St Luke s Medical Center Aurora
Milwaukee, Wisconsin, United States
Novartis Investigative Site
Rosario, Santa Fe Province, Argentina
Novartis Investigative Site
Rosario, Santa Fe Province, Argentina
Novartis Investigative Site
Buenos Aires, , Argentina
Novartis Investigative Site
Córdoba, , Argentina
Novartis Investigative Site
San Miguel de Tucumán, , Argentina
Novartis Investigative Site
New Lambton Heights, New South Wales, Australia
Novartis Investigative Site
Liverpool, , Australia
Novartis Investigative Site
St Leonards, , Australia
Novartis Investigative Site
Vienna, Vienna, Austria
Novartis Investigative Site
Vienna, , Austria
Novartis Investigative Site
Brasschaat, , Belgium
Novartis Investigative Site
Bruges, , Belgium
Novartis Investigative Site
Brussels, , Belgium
Novartis Investigative Site
Edegem, , Belgium
Novartis Investigative Site
Ghent, , Belgium
Novartis Investigative Site
Sofia, Bulgaria, Bulgaria
Novartis Investigative Site
Sofia, Bulgaria, Bulgaria
Novartis Investigative Site
Pleven, , Bulgaria
Novartis Investigative Site
Sofia, , Bulgaria
Novartis Investigative Site
Sofia, , Bulgaria
Novartis Investigative Site
London, Ontario, Canada
Novartis Investigative Site
Ottawa, Ontario, Canada
Novartis Investigative Site
Toronto, Ontario, Canada
Novartis Investigative Site
Gatineau, Quebec, Canada
Novartis Investigative Site
Greenfield Park, Quebec, Canada
Novartis Investigative Site
Montreal, Quebec, Canada
Novartis Investigative Site
Québec, Quebec, Canada
Novartis Investigative Site
Osijek, , Croatia
Novartis Investigative Site
Rijeka, , Croatia
Novartis Investigative Site
Zagreb, , Croatia
Novartis Investigative Site
Brno, , Czechia
Novartis Investigative Site
Havířov, , Czechia
Novartis Investigative Site
Hradec Králové, , Czechia
Novartis Investigative Site
Jihlava, , Czechia
Novartis Investigative Site
Olomouc, , Czechia
Novartis Investigative Site
Pardubice, , Czechia
Novartis Investigative Site
Prague, , Czechia
Novartis Investigative Site
Prague, , Czechia
Novartis Investigative Site
Prague, , Czechia
Novartis Investigative Site
Prague, , Czechia
Novartis Investigative Site
Teplice, , Czechia
Novartis Investigative Site
Glostrup Municipality, , Denmark
Novartis Investigative Site
Odense C, , Denmark
Novartis Investigative Site
Tallinn, , Estonia
Novartis Investigative Site
Tartu, , Estonia
Novartis Investigative Site
Tampere, , Finland
Novartis Investigative Site
Turku, , Finland
Novartis Investigative Site
Lille, , France
Novartis Investigative Site
Montpellier, , France
Novartis Investigative Site
Nantes, , France
Novartis Investigative Site
Nice, , France
Novartis Investigative Site
Nîmes, , France
Novartis Investigative Site
Paris, , France
Novartis Investigative Site
Strasbourg, , France
Novartis Investigative Site
Munich, Bavaria, Germany
Novartis Investigative Site
Neuburg an der Donau, Bavaria, Germany
Novartis Investigative Site
Marburg, Hesse, Germany
Novartis Investigative Site
Cologne, North Rhine-Westphalia, Germany
Novartis Investigative Site
Dresden, Saxony, Germany
Novartis Investigative Site
Leipzig, Saxony, Germany
Novartis Investigative Site
Barsinghausen, , Germany
Novartis Investigative Site
Bayreuth, , Germany
Novartis Investigative Site
Bielefeld, , Germany
Novartis Investigative Site
Bochum, , Germany
Novartis Investigative Site
Essen, , Germany
Novartis Investigative Site
Hamburg, , Germany
Novartis Investigative Site
Hanover, , Germany
Novartis Investigative Site
Heidelberg, , Germany
Novartis Investigative Site
Minden, , Germany
Novartis Investigative Site
München, , Germany
Novartis Investigative Site
Potsdam, , Germany
Novartis Investigative Site
Siegen, , Germany
Novartis Investigative Site
Ulm, , Germany
Novartis Investigative Site
Unterhaching, , Germany
Novartis Investigative Site
Athens, , Greece
Novartis Investigative Site
Thessaloniki, , Greece
Novartis Investigative Site
Budapest, HUN, Hungary
Novartis Investigative Site
Budapest, , Hungary
Novartis Investigative Site
Budapest, , Hungary
Novartis Investigative Site
Budapest, , Hungary
Novartis Investigative Site
Kistarcsa, , Hungary
Novartis Investigative Site
Pécs, , Hungary
Novartis Investigative Site
Szeged, , Hungary
Novartis Investigative Site
Kochi, Kerala, India
Novartis Investigative Site
Mumbai, Maharashtra, India
Novartis Investigative Site
Pune, Maharashtra, India
Novartis Investigative Site
New Delhi, National Capital Territory of Delhi, India
Novartis Investigative Site
New Delhi, National Capital Territory of Delhi, India
Novartis Investigative Site
Chandigarh, Punjab, India
Novartis Investigative Site
Hyderabad, Telangana, India
Novartis Investigative Site
Howrah, West Bengal, India
Novartis Investigative Site
Mangalore, , India
Novartis Investigative Site
Ashkelon, , Israel
Novartis Investigative Site
Haifa, , Israel
Novartis Investigative Site
Sefad, , Israel
Novartis Investigative Site
Tel Aviv, , Israel
Novartis Investigative Site
Chiba, Chiba, Japan
Novartis Investigative Site
Tōon, Ehime, Japan
Novartis Investigative Site
Sapporo, Hokkaido, Japan
Novartis Investigative Site
Morioka, Iwate, Japan
Novartis Investigative Site
Sendai, Miyagi, Japan
Novartis Investigative Site
Sendai, Miyagi, Japan
Novartis Investigative Site
Kawagoe, Saitama, Japan
Novartis Investigative Site
Kodaira, Tokyo, Japan
Novartis Investigative Site
Shinjuku-ku, Tokyo, Japan
Novartis Investigative Site
Niigata, , Japan
Novartis Investigative Site
Osaka, , Japan
Novartis Investigative Site
Riga, LV, Latvia
Novartis Investigative Site
Riga, , Latvia
Novartis Investigative Site
Riga, , Latvia
Novartis Investigative Site
Kaunas, LTU, Lithuania
Novartis Investigative Site
Vilnius, , Lithuania
Novartis Investigative Site
Mexico City, Mexico City, Mexico
Novartis Investigative Site
Mexico City, Mexico City, Mexico
Novartis Investigative Site
Chihuahua City, , Mexico
Novartis Investigative Site
Sittard-Geleen, Limburg, Netherlands
Novartis Investigative Site
Amsterdam, North Holland, Netherlands
Novartis Investigative Site
Rotterdam, South Holland, Netherlands
Novartis Investigative Site
Drammen, , Norway
Novartis Investigative Site
Lima Cercado, Lima region, Peru
Novartis Investigative Site
San Isidro, Lima region, Peru
Novartis Investigative Site
Lima, , Peru
Novartis Investigative Site
Bydgoszcz, Woj Kujawsko Pomorskie, Poland
Novartis Investigative Site
Gdansk, , Poland
Novartis Investigative Site
Gdansk, , Poland
Novartis Investigative Site
Glogow Wielkopolski, , Poland
Novartis Investigative Site
Katowice, , Poland
Novartis Investigative Site
Kielce, , Poland
Novartis Investigative Site
Lodz, , Poland
Novartis Investigative Site
Poznan, , Poland
Novartis Investigative Site
Rzeszów, , Poland
Novartis Investigative Site
Warsaw, , Poland
Novartis Investigative Site
Wroclaw, , Poland
Novartis Investigative Site
Zabrze, , Poland
Novartis Investigative Site
Braga, , Portugal
Novartis Investigative Site
Coimbra, , Portugal
Novartis Investigative Site
Lisbon, , Portugal
Novartis Investigative Site
Lisbon, , Portugal
Novartis Investigative Site
Loures, , Portugal
Novartis Investigative Site
Matosinhos Municipality, , Portugal
Novartis Investigative Site
Porto, , Portugal
Novartis Investigative Site
Santa Maria da Feira, , Portugal
Novartis Investigative Site
Kazan', , Russia
Novartis Investigative Site
Kemerovo, , Russia
Novartis Investigative Site
Krasnoyarsk, , Russia
Novartis Investigative Site
Moscow, , Russia
Novartis Investigative Site
Moscow, , Russia
Novartis Investigative Site
Nizhny Novgorod, , Russia
Novartis Investigative Site
Nizhny Novgorod, , Russia
Novartis Investigative Site
Novosibirsk, , Russia
Novartis Investigative Site
Novosibirsk, , Russia
Novartis Investigative Site
Saint Petersburg, , Russia
Novartis Investigative Site
Saint Petersburg, , Russia
Novartis Investigative Site
Saint Petersburg, , Russia
Novartis Investigative Site
Saint Petersburg, , Russia
Novartis Investigative Site
Saransk, , Russia
Novartis Investigative Site
Sestroretsk, , Russia
Novartis Investigative Site
Tyumen, , Russia
Novartis Investigative Site
Yekaterinburg, , Russia
Novartis Investigative Site
Banská Bystrica, Slovakia, Slovakia
Novartis Investigative Site
Bratislava, Slovakia, Slovakia
Novartis Investigative Site
Bratislava, Slovakia, Slovakia
Novartis Investigative Site
Bratislava, Slovakia, Slovakia
Novartis Investigative Site
Martin, Slovakia, Slovakia
Novartis Investigative Site
Nitra, Slovakia, Slovakia
Novartis Investigative Site
Trnava, Slovakia, Slovakia
Novartis Investigative Site
Pretoria, , South Africa
Novartis Investigative Site
Rosebank, , South Africa
Novartis Investigative Site
Cadiz, Andalusia, Spain
Novartis Investigative Site
Seville, Andalusia, Spain
Novartis Investigative Site
L'Hospitalet de Llobregat, Barcelona, Spain
Novartis Investigative Site
Donostia / San Sebastian, Basque Country, Spain
Novartis Investigative Site
Barcelona, Catalonia, Spain
Novartis Investigative Site
Barcelona, Catalonia, Spain
Novartis Investigative Site
Salt, Girona, Spain
Novartis Investigative Site
Majadahonda, Madrid, Spain
Novartis Investigative Site
Pozuelo de Alarcón, Madrid, Spain
Novartis Investigative Site
El Palmar, Murcia, Spain
Novartis Investigative Site
Castilleja de la Cuesta, Sevilla, Spain
Novartis Investigative Site
Barakaldo, Vizcaya, Spain
Novartis Investigative Site
Barcelona, , Spain
Novartis Investigative Site
Barcelona, , Spain
Novartis Investigative Site
Madrid, , Spain
Novartis Investigative Site
Madrid, , Spain
Novartis Investigative Site
Madrid, , Spain
Novartis Investigative Site
Málaga, , Spain
Novartis Investigative Site
Valencia, , Spain
Novartis Investigative Site
Gothenburg, , Sweden
Novartis Investigative Site
Stockholm, , Sweden
Novartis Investigative Site
Basel, , Switzerland
Novartis Investigative Site
Lugano, , Switzerland
Novartis Investigative Site
Tainan, , Taiwan
Novartis Investigative Site
Khon Kaen, THA, Thailand
Novartis Investigative Site
Samsun, Atakum, Turkey (Türkiye)
Novartis Investigative Site
Istanbul, Bakirkoy, Turkey (Türkiye)
Novartis Investigative Site
Izmir, Balcova, Turkey (Türkiye)
Novartis Investigative Site
Istanbul, Fatih, Turkey (Türkiye)
Novartis Investigative Site
Izmir, Karsiyaka, Turkey (Türkiye)
Novartis Investigative Site
Köseköy, Kocaeli, Turkey (Türkiye)
Novartis Investigative Site
Trabzon, Ortahisar, Turkey (Türkiye)
Novartis Investigative Site
Istanbul, Sancaktepe, Turkey (Türkiye)
Novartis Investigative Site
Istanbul, Sultangazi, Turkey (Türkiye)
Novartis Investigative Site
Mersin, Yenisehir, Turkey (Türkiye)
Novartis Investigative Site
Izmir, , Turkey (Türkiye)
Novartis Investigative Site
Luton, Beds, United Kingdom
Novartis Investigative Site
Glasgow, Scotland, United Kingdom
Novartis Investigative Site
Sheffield, South Yorkshire, United Kingdom
Novartis Investigative Site
London, , United Kingdom
Novartis Investigative Site
London, , United Kingdom
Novartis Investigative Site
Oxford, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hauser SL, Cohen JA, de Seze J, Meuth SG, Giacomini PS, Nakahara J, Oreja-Guevara C, Robertson D, Wray S, Bhatt A, Hu X, Xi J, Piccolo R, Jehl V, Sullivan R, Boer I, Wiendl H, Kappos L. Five-Year Safety and Efficacy Outcomes with Ofatumumab in Patients with Relapsing Multiple Sclerosis. Neurol Ther. 2025 Oct;14(5):1975-1992. doi: 10.1007/s40120-025-00784-0. Epub 2025 Jul 13.
Hauser SL, Zielman R, Das Gupta A, Xi J, Stoneman D, Karlsson G, Robertson D, Cohen JA, Kappos L. Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The ALITHIOS open-label extension. Mult Scler. 2023 Oct;29(11-12):1452-1464. doi: 10.1177/13524585231195346. Epub 2023 Sep 11.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COMB157G2399
Identifier Type: -
Identifier Source: org_study_id